Skip to main content
Clinical Trials/JPRN-UMIN000037967
JPRN-UMIN000037967
Completed
未知

A multicenter prospective observational study of atezolizumab plus bevacizumab plus carboplatin plus paclitaxel (ABCP) in patients with unresectable advanced or relapsed EGFR-mutation positive nonsquamous non-small-cell lung cancer: ABCP observational study - ABCP multicenter prospective observational study

Department of Thoracic Oncology, Kansai Medical University Hospital0 sites142 target enrollmentSeptember 10, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
non-small-cell lung cancer
Sponsor
Department of Thoracic Oncology, Kansai Medical University Hospital
Enrollment
142
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 10, 2019
End Date
February 28, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of Thoracic Oncology, Kansai Medical University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • A Patient who is judged ineligible to enroll the study by an attending doctor.

Outcomes

Primary Outcomes

Not specified

Similar Trials